- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 47/65 - Peptidic linkers, binders or spacers, e.g. peptidic enzyme-labile linkers
Patent holdings for IPC class A61K 47/65
Total number of patents in this class: 1552
10-year publication summary
|
50
|
65
|
123
|
211
|
211
|
200
|
197
|
207
|
224
|
2
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Regents of the University of California | 19479 |
30 |
| SeaGen Inc | 580 |
25 |
| Daiichi Sankyo Company, Limited | 1863 |
23 |
| Bayer Pharma AG | 1085 |
20 |
| CytomX Therapeutics, Inc. | 215 |
16 |
| MedImmune Limited | 624 |
15 |
| Bicyclerd Limited | 138 |
15 |
| Genentech, Inc. | 3864 |
14 |
| Shanghai Hengrui Pharmaceutical Co., Ltd. | 627 |
14 |
| SynDevRx, Inc. | 45 |
14 |
| Cornell University | 3184 |
12 |
| Bristol-myers Squibb Company | 4886 |
11 |
| Duke University | 3003 |
11 |
| Purdue Research Foundation | 3472 |
11 |
| ImmunoGen, Inc. | 406 |
11 |
| Genequantum Healthcare (Suzhou) Co., Ltd. | 53 |
11 |
| The Johns Hopkins University | 5519 |
10 |
| Blaze BioScience, Inc. | 78 |
10 |
| Case Western Reserve University | 1769 |
10 |
| Immunwork Inc. | 25 |
10 |
| Other owners | 1259 |